Literature DB >> 17869342

T cell allorecognition and MHC restriction--A case of Jekyll and Hyde?

Julia K Archbold1, Lauren K Ely, Lars Kjer-Nielsen, Scott R Burrows, Jamie Rossjohn, James McCluskey, Whitney A Macdonald.   

Abstract

A great paradox in cellular immunology is how T cell allorecognition exists at high frequencies (up to 10%) despite the stringent requirements of discriminating 'self' from 'non-self' imposed by MHC restriction. Thus, in tissue transplantation, a substantial proportion of the recipient's T cells will have the ability to recognize the graft and instigate an immune response against the transplanted tissue, ultimately resulting in graft rejection--a manifestation of T cell alloreactivity. Transplantation of human organs and lymphoid cells as treatment for otherwise life-threatening diseases has become a more routine medical procedure making this problem of great importance. Immunologists have gained important insights into the mechanisms of T cell alloreactivity from cytotoxic T cell assays, affinity-avidity studies, and crystal structures of peptide-MHC (pMHC) molecules and T cell receptors (TCRs) both alone and in complex. Despite the clinical significance of alloreactivity, the crystal structure of an alloreactive human TCR in complex with both cognate pMHC and an allogeneic pMHC complex has yet to be determined. This review highlights some of the important findings from studies characterizing the way in which alloreactive T cell receptors and pMHC molecules interact in an attempt to resolve this great irony of the cellular immune response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17869342     DOI: 10.1016/j.molimm.2006.05.018

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  11 in total

1.  Simultaneous Recognition of Allogeneic MHC and Cognate Autoantigen by Autoreactive T Cells in Transplant Rejection.

Authors:  Adam L Burrack; Laurie G Landry; Janet Siebert; Marilyne Coulombe; Ronald G Gill; Maki Nakayama
Journal:  J Immunol       Date:  2018-01-08       Impact factor: 5.422

2.  Cell surface display of functional human MHC class II proteins: yeast display versus insect cell display.

Authors:  Fei Wen; Dhruv K Sethi; Kai W Wucherpfennig; Huimin Zhao
Journal:  Protein Eng Des Sel       Date:  2011-07-13       Impact factor: 1.650

3.  First-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejection.

Authors:  S M Flechner; S Mulgoankar; L B Melton; T H Waid; A Agarwal; S D Miller; F Fokta; M T Getts; T J Frederick; J J Herrman; J P Puisis; L O'Toole; R Sung; F Shihab; A C Wiseman; D R Getts
Journal:  Am J Transplant       Date:  2014-04-17       Impact factor: 8.086

4.  HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States.

Authors:  Lee Ann Baxter-Lowe; Martin Maiers; Stephen R Spellman; Michael D Haagenson; Tao Wang; Marcelo Fernandez-Vina; Steven G E Marsh; Mary Horowitz; Carolyn Katovich Hurley
Journal:  Biol Blood Marrow Transplant       Date:  2009-08       Impact factor: 5.742

5.  The pharmacokinetics and pharmacodynamics of TOL101, a murine IgM anti-human αβ T cell receptor antibody, in renal transplant patients.

Authors:  Daniel R Getts; William G Kramer; Alexander C Wiseman; Stuart M Flechner
Journal:  Clin Pharmacokinet       Date:  2014-07       Impact factor: 6.447

6.  Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation.

Authors:  S R Marino; S Lin; M Maiers; M Haagenson; S Spellman; J P Klein; T A Binkowski; S J Lee; K van Besien
Journal:  Bone Marrow Transplant       Date:  2011-03-28       Impact factor: 5.483

7.  A single autoimmune T cell receptor recognizes more than a million different peptides.

Authors:  Linda Wooldridge; Julia Ekeruche-Makinde; Hugo A van den Berg; Anna Skowera; John J Miles; Mai Ping Tan; Garry Dolton; Mathew Clement; Sian Llewellyn-Lacey; David A Price; Mark Peakman; Andrew K Sewell
Journal:  J Biol Chem       Date:  2011-11-18       Impact factor: 5.157

8.  The somatically generated portion of T cell receptor CDR3α contributes to the MHC allele specificity of the T cell receptor.

Authors:  Philippa Marrack; Sai Harsha Krovi; Daniel Silberman; Janice White; Eleanor Kushnir; Maki Nakayama; James Crooks; Thomas Danhorn; Sonia Leach; Randy Anselment; James Scott-Browne; Laurent Gapin; John Kappler
Journal:  Elife       Date:  2017-11-17       Impact factor: 8.140

9.  Highly divergent T-cell receptor binding modes underlie specific recognition of a bulged viral peptide bound to a human leukocyte antigen class I molecule.

Authors:  Yu Chih Liu; John J Miles; Michelle A Neller; Emma Gostick; David A Price; Anthony W Purcell; James McCluskey; Scott R Burrows; Jamie Rossjohn; Stephanie Gras
Journal:  J Biol Chem       Date:  2013-04-08       Impact factor: 5.157

Review 10.  Mucins help to avoid alloreactivity at the maternal fetal interface.

Authors:  Arnela Redzovic; Gordana Laskarin; Marin Dominovic; Herman Haller; Daniel Rukavina
Journal:  Clin Dev Immunol       Date:  2013-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.